Search results :

Terbinafine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: D01AE15, D01BA02

Side effects

Options: Hide MedDRA Preferred Terms ,   display all 22 labels

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Abdominal pain Abdominal cramps very common x x x
Abdominal pain 0% - 2.4% 0% - 1.5% x x x x x x x x x x x x x x x
Decreased appetite Anorexia very common x x x x x x x
Appetite absent very common x x x x x x
Decreased appetite x
Eructation Eructation very common x x x
Gastritis Gastritis very common, 2.2% - 22% x x x x x x x
Abdominal discomfort Abdominal discomfort very common x x x
Nasopharyngitis Nasopharyngitis 10% - 11% x
Rhinorrhoea 0% - 2% x
Headache Headache common, 0.2% - 12.9% 0% - 9.5% x x x x x x x x x x x x x x x x x
Cough Cough 5% - 6% x
Muscle spasms Cramp muscle 1% - 10% x x x x
Erythema Erythema common, 0.9% - 9% x x x x x x x
Redness x
Upper respiratory tract infection Upper respiratory tract infection 5% x
Abdominal pain upper Abdominal pain upper 4% x
Diarrhoea Diarrhoea very common, 0% - 10% 0% - 2.9% x x x x x x x x x x x x x x x x x x
Dyspepsia Dyspepsia very common, 0% - 22% 0% - 2.9% x x x x x x x x x x x x x x x x x x
Dizziness Dizziness very rare, common x x x x x
Lightheadedness very rare x x x
Nausea Nausea very common, 0% - 11% 0% - 2.9% x x x x x x x x x x x x x x x x x
Flatulence Flatulence very common, 0% - 2.2% 0% - 2.2% x x x x x x x x x x x x
Dermatitis Rash common, 0.7% - 9% 0.7% - 2.2% x x x x x x x x x x x x x x x x x x
Rash Rash common, 0.7% - 9% 0.7% - 2.2% x x x x x x x x x x x x x x x x x x
Eruption very rare x x x
Laryngeal pain Pharyngolaryngeal pain 2% x
Skin disorder Skin disorder 1.9% x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x
Gastrointestinal pain Abdominal pain 0% - 2.4% 0% - 1.5% x x x x x x x x x x x x x x x
Influenza Influenza 1% - 2% x
Nasal congestion Nasal congestion 1% - 2% x
Pruritus Pruritus common, 0% - 4% 0% - 1.5% x x x x x x x x x x x x x x x x x x x x
Toothache Toothache 1% x
Skin exfoliation Skin exfoliation 1% x x
Rhinorrhoea Rhinorrhoea 0% - 2% x
Visual impairment Visual disturbance 0% - 1.5% 0% - 1.5% x x x x x x x x x
Visual impairment x
Rash erythematous Rash erythematous 0.9% x
Urticaria Urticaria common, 0% - 5% 0% x x x x x x x x x x x x x x x x x x
Vomiting Vomiting postmarketing — 1.1% - 11% x x x x x x x x x x x x x x x x x x
Eczema Eczema 0.1% - 1% x x x x
Hypoglycaemia Hypoglycaemia 0.1% - 1% x x x x
Pain Pain 0.1% - 1% x x x x
Stinging x
Dry mouth Dry mouth 0.1% - 1% x x x x
Malaise Sickness 0.1% - 1% x x x x
Malaise postmarketing x x x x x x x x x x x x x x x
Hepatic enzyme increased Hepatic enzyme increased 0.1% - 1% x x x x
Agranulocytosis Agranulocytosis very rare, postmarketing x x x x x x x x x x x x x x x x x x
Alopecia Alopecia postmarketing x x x x x x x x x x x x x x x x x x
Anaphylactic shock Anaphylactic shock postmarketing x x x x x x x x x x x x x x x x x
Anaphylactoid reaction very rare x x x x
Anaemia Anaemia postmarketing x x x x x x x x x x x x x
Angioedema Angioedema very rare, postmarketing x x x x x x x x x x x x x x x x x x
Anosmia Anosmia postmarketing x x x x x x x x x x x
Anxiety Anxiety postmarketing x x x x x
Arthralgia Arthralgia postmarketing, very common x x x x x x x x x x x x x x x x x x
Musculoskeletal discomfort Arthralgia postmarketing, very common x x x x x x x x x x x x x x x x x x
Myalgia postmarketing, very common x x x x x x x x x x x x x x x x x x
Mental disorder Mental disorder postmarketing x x x x
Cholestasis Cholestasis postmarketing x x x
Connective tissue disorder Connective tissue disorder postmarketing x x x x x x
Dermatitis exfoliative Dermatitis exfoliative postmarketing x x x x
Dysgeusia Dysgeusia postmarketing — 0% - 2.8% 0% - 0.7% x x x x x x x x x x x x
Eosinophilia Eosinophilia postmarketing x x x x
Toxic epidermal necrolysis Toxic epidermal necrolysis postmarketing x x x x x x x x x x x x x x x
Erythema multiforme Erythema multiforme postmarketing x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x
Eye disorder Eye disorder postmarketing x x x x
Asthenia Fatigue very rare — 0.3% - 3% x x x x x x x x x x x x x x x x x x
Fatigue Fatigue very rare — 0.3% - 3% x x x x x x x x x x x x x x x x x x
Body temperature increased Body temperature increased postmarketing, 6% - 7% x x x x x x x x x x x
Gastrointestinal disorder Gastrointestinal disorder postmarketing x x x x x
Gastrointestinal symptom NOS x x x x x x x x x x
Hepatitis Hepatitis postmarketing x x x
Hypersensitivity Hypersensitivity postmarketing x x x x x x x x x x x x x x x x
Hypoaesthesia Hypoaesthesia very rare — uncommon x x x x x x x x
Immune system disorder Immune system disorder postmarketing x x x x x
Jaundice cholestatic Jaundice cholestatic rare x x x
Systemic lupus erythematosus Systemic lupus erythematosus very rare, postmarketing x x x x x x x x x x x x x x x x
Lupus erythematosus x x
Nervous system disorder Nervous system disorder postmarketing x x x x x x
Neutropenia Neutropenia very rare, postmarketing x x x x x x x x x x x x x x x x x x
Pancreatitis Pancreatitis postmarketing x x x x x x x x x x x
Pancytopenia Pancytopenia very rare, postmarketing x x x x x x x x x x x x x x x
Paraesthesia Paraesthesia very rare — uncommon x x x x x x x x
Rhabdomyolysis Rhabdomyolysis postmarketing x x x x x x x x x x x x x
Scotoma Scotoma postmarketing x x x x x x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x
Thrombocytopenia Thrombocytopenia very rare, postmarketing x x x x x x x x x x x x x x x x x x
Tinnitus Tinnitus postmarketing x x x x x x x
Angiopathy Angiopathy postmarketing x x x x x x
Vasculitis Vasculitis postmarketing x x x x x x x x x x
Vertigo Vertigo postmarketing x x x x x
Weight decreased Weight decreased postmarketing x x x x x x x x x x x x x x x x x
Hepatic failure Hepatic failure very rare — rare x x x x x x x x x x x x x x x x x x
Dermatitis bullous Dermatitis bullous postmarketing x x x x
Bullous eruption x
Depressive symptom Depressive symptom postmarketing x x x x x x x x x x
Liver injury Liver injury postmarketing x x x x x x x x x x x
Traumatic liver injury Liver injury postmarketing x x x x x x x x x x x
Photosensitivity reaction Photosensitivity reaction postmarketing x x x x x x x x x
Photosensitivity allergic reaction x
Photosensitivity x x x x
Serum sickness-like reaction Serum sickness-like reaction postmarketing x x x x x x x x x x x
Discomfort Malaise postmarketing x x x x x x x x x x x x x x x
Feeling abnormal Malaise postmarketing x x x x x x x x x x x x x x x
Confusional state x
Ill-defined disorder Malaise postmarketing x x x x x x x x x x x x x x x
Myalgia Myalgia postmarketing, very common x x x x x x x x x x x x x x x x x x
Visual acuity reduced Visual acuity reduced postmarketing x x x x x x x x x
Psoriasis Psoriasis flare-up very rare, postmarketing x x x x x x x x x x x x x x x
Dermatitis psoriasiform Dermatitis psoriasiform postmarketing x x x x x x x x x x x x
Hepatobiliary disease Hepatobiliary disease postmarketing x x x x x
Influenza like illness Influenza like illness postmarketing x x x x x x x x x x x
Blood creatine phosphokinase increased Blood creatine phosphokinase increased postmarketing x x x x x x x x x x x
Vasculitis gastrointestinal Vasculitis gastrointestinal postmarketing x
Acute generalised exanthematous pustulosis Acute generalised exanthematous pustulosis postmarketing x x x x x x x x x x x x x x x
Deafness Hearing impaired postmarketing x x x x x x x
Hearing impaired Hearing impaired postmarketing x x x x x x x
Partial hearing loss x x
Ageusia Ageusia postmarketing — common x x x x x x x x x x x x x x x x x x
Chest pain Chest pain very rare x x x
Blood disorder Blood disorder very rare x x x x x x x
Anaphylactoid reaction Anaphylactoid reaction very rare x x x x
Arthritis Arthritis x x x x
Infection Infection x x
Confusional state Confusional state x
Drug eruption Drug eruption x
Dermatitis contact Dermatitis contact x
Ear disorder Ear disorder x x
Jaundice Jaundice x x x x
Liver disorder Liver disorder x x x x
Hepatocellular injury Liver disorder x x x x
Foetor hepaticus Liver disorder x x x x
Polymorphic light eruption Polymorphic light eruption x
Thrombotic thrombocytopenic purpura Thrombotic thrombocytopenic purpura x x x x
Serum sickness Serum sickness x x x x
Hepatic function abnormal Hepatic function abnormal x x x x
Skin discolouration Skin discolouration x
Hypogeusia Hypogeusia x
Skin hyperpigmentation Skin hyperpigmentation x
Vision blurred Vision blurred x
Rash generalised Rash generalised x
Toxic skin eruption Toxic skin eruption x
Haematocrit decreased Haematocrit decreased x
Infestation Infestation NOS x
Blood urea increased Serum urea increased x x
Photodermatosis Photodermatosis x
Hyposmia Hyposmia x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

TERBINAFINE / LAMISIL

Side effects:6
Source:FDA

terbinafine hydrochloride / Lamisil

Side effects:29
Source:FDA

TERBINAFINE

Side effects:32
Source:FDA Structured Product Label

Terbinafine

Side effects:32
Source:FDA Structured Product Label

TERBINAFINE

Side effects:47
Source:FDA Structured Product Label

TERBINAFINE

Side effects:47
Source:FDA Structured Product Label

Terbinafine

Side effects:48
Source:FDA Structured Product Label

TERBINAFINE

Side effects:48
Source:FDA Structured Product Label

TERBINAFINE

Side effects:51
Source:FDA Structured Product Label

TERBINAFINE HYDROCHLORIDE / LAMISIL SPRAY

Side effects:61
Source:Health Canada

Terbinafine hydrochloride / Tinasil

Side effects:63
Source:medicines.org.au

TERBINAFINE

Side effects:70
Source:FDA Structured Product Label

TERBINAFINE

Side effects:71
Source:FDA Structured Product Label

Terbinafine (as hydrochloride) / TERBINAFINE

Side effects:72
Source:medicines.org.au

TERBINAFINE

Side effects:80
Source:FDA Structured Product Label

terbinafine hydrochloride / LAMISIL TABLETS

Side effects:83
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label